Core Viewpoint - New Oxygen (SY) experienced a 5.19% increase in stock price, reaching $4.26 per share, with a total market capitalization of $423 million as of August 25 [1] Financial Performance - As of June 30, 2025, New Oxygen reported total revenue of 676 million RMB, reflecting a year-on-year decrease of 6.84% [1] - The company's net profit attributable to shareholders was -69.18 million RMB, showing a significant year-on-year decline of 2909% [1] Major Events - On August 19, New Oxygen received a maintained "Buy" rating from Haitong International, with the target price raised to $10.30 [1] Company Overview - New Oxygen International is focused on leveraging technology to assist women in enhancing their beauty and health [1] - The founder established New Oxygen to provide transparent information, aiming to transform the rapidly growing yet opaque medical aesthetics market in China [1] - The company seeks to create a one-stop platform for users to easily find quality services [1]

Group 1 - The core viewpoint of the article highlights that Xinyang (SY) experienced a stock price increase of 5.12%, reaching $3.9 per share, with a total market capitalization of $387 million as of August 20 [1] - Financial data indicates that as of June 30, 2025, Xinyang's total revenue was 676 million RMB, representing a year-on-year decrease of 6.84%, while the net profit attributable to shareholders was -69.177 million RMB, reflecting a significant year-on-year decline of 2909% [1] - On August 19, Xinyang received a rating upgrade from Haitong International, maintaining a "Buy" rating and raising the target price to $10.3 [1] Group 2 - Xinyang International is a company focused on leveraging technology to assist women in enhancing their health and beauty [1] - The founder established Xinyang to provide transparent information, aiming to transform the rapidly growing but opaque medical aesthetics market in China, ultimately creating a one-stop platform for users to easily find quality services [1]

Group 1 - The core viewpoint of the article highlights the recent performance of Xinyang (SY), which saw a 2.07% increase in stock price, reaching $3.69 per share, with a total market capitalization of $366 million as of August 19 [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue amounted to 297 million RMB, reflecting a year-on-year decrease of 6.6%, while the net profit attributable to shareholders was -33.138 million RMB, a decline of 56.02% year-on-year [1] - Xinyang is positioned as a technology-driven company aimed at enhancing women's health and beauty, providing a transparent platform in China's rapidly growing but opaque medical aesthetics market [2] Group 2 - A significant event reminder states that Xinyang is scheduled to disclose its fiscal year 2025 mid-term report on August 15, prior to the market opening [2] - The company was founded to transform the medical aesthetics market by offering transparent information, ultimately creating a one-stop platform for users to easily find quality services [2]

8月15日，新氧将于(美东)盘前披露2025财年中报（数据来源于纳斯达克官网，预计披露日期为美国当 地时间，实际披露日期以公司公告为准）。 资料显示，新氧国际公司是一家致力于用科技的方式帮助爱美女性健康变美的公司。创始人成立了新 氧,通过提供透明的信息,改变中国快速增长但不透明的医学美学市场,最终使他们能够建立一个一站式的 平台,用户可以方便地找到优质的服务。 本文源自：金融界 作者：行情君 8月13日，新氧(SY)开盘上涨2.08%，截至21:30，报4.91美元/股，成交45.63万美元，总市值4.92亿美 元。 财务数据显示，截至2025年03月31日，新氧收入总额2.97亿人民币，同比减少6.6%；归母净利润-3313.8 万人民币，同比减少56.02%。 大事提醒： ...

8月15日，新氧将于(美东)盘前披露2025财年中报（数据来源于纳斯达克官网，预计披露日期为美国当 地时间，实际披露日期以公司公告为准）。 8月4日，新氧(SY)盘中上涨10.19%，截至23:06，报4.76美元/股，成交272.35万美元，总市值4.77亿美 元。 财务数据显示，截至2025年03月31日，新氧收入总额2.97亿人民币，同比减少6.6%；归母净利润-3313.8 万人民币，同比减少56.02%。 大事提醒： 资料显示，新氧国际公司是一家致力于用科技的方式帮助爱美女性健康变美的公司。创始人成立了新 氧,通过提供透明的信息,改变中国快速增长但不透明的医学美学市场,最终使他们能够建立一个一站式的 平台,用户可以方便地找到优质的服务。 本文源自金融界 ...

Group 1 - The stock price of Xinyang (SY) increased by 8.91% on August 4, closing at $4.705 per share, with a total trading volume of $1.2899 million and a market capitalization of $472 million [1] - As of March 31, 2025, Xinyang reported total revenue of 297 million RMB, a year-on-year decrease of 6.6%, and a net profit attributable to shareholders of -33.138 million RMB, representing a year-on-year decrease of 56.02% [1] Group 2 - Xinyang is scheduled to release its fiscal year 2025 mid-term report on August 15, before the market opens (Eastern Time) [2] - Xinyang International Company aims to leverage technology to assist women in enhancing their health and beauty, providing transparent information to transform the rapidly growing but opaque medical aesthetics market in China [2]

8月15日，新氧将于(美东)盘前披露2025财年中报（数据来源于纳斯达克官网，预计披露日期为美国当 地时间，实际披露日期以公司公告为准）。 资料显示，新氧国际公司是一家致力于用科技的方式帮助爱美女性健康变美的公司。创始人成立了新 氧,通过提供透明的信息,改变中国快速增长但不透明的医学美学市场,最终使他们能够建立一个一站式的 平台,用户可以方便地找到优质的服务。 本文源自：金融界 7月29日，新氧(SY)盘中上涨2.17%，截至22:20，报5.17美元/股，成交383.42万美元，总市值5.18亿美 元。 财务数据显示，截至2025年03月31日，新氧收入总额2.97亿人民币，同比减少6.6%；归母净利润-3313.8 万人民币，同比减少56.02%。 大事提醒： 作者：行情君 ...